| scholarly article | Q13442814 |
| P356 | DOI | 10.1126/SCIENCE.1082015 |
| P698 | PubMed publication ID | 12843393 |
| P2093 | author name string | David A Cheresh | |
| Dwayne G Stupack | |||
| John D Hood | |||
| Ricardo Frausto | |||
| Alireza Alavi | |||
| P433 | issue | 5629 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| P304 | page(s) | 94-96 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | Science | Q192864 |
| P1476 | title | Role of Raf in vascular protection from distinct apoptotic stimuli | |
| P478 | volume | 301 |
| Q35600821 | A MEK-independent role for CRAF in mitosis and tumor progression. |
| Q37534963 | A critical analysis of current in vitro and in vivo angiogenesis assays |
| Q35601503 | A small molecule disruptor of Rb/Raf-1 interaction inhibits cell proliferation, angiogenesis, and growth of human tumor xenografts in nude mice. |
| Q35032965 | A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo |
| Q34099797 | Activated STAT3 is a mediator and biomarker of VEGF endothelial activation |
| Q38389975 | Angiogenesis in cancer: Anti-VEGF escape mechanisms |
| Q35710217 | Angiogenic sprouting requires the fine tuning of endothelial cell cohesion by the Raf-1/Rok-α complex |
| Q33583598 | Antivascular therapy for epithelial ovarian cancer |
| Q37644750 | Apoptosis and inflammation associated gene expressions in monocrotaline-induced pulmonary hypertensive rats after bosentan treatment |
| Q40464878 | Apoptosis of hematopoietic cells induced by growth factor withdrawal is associated with caspase-9 mediated cleavage of Raf-1. |
| Q41301518 | Asymmetric division coordinates collective cell migration in angiogenesis |
| Q37203920 | Azaspirene, a fungal product, inhibits angiogenesis by blocking Raf-1 activation |
| Q40543086 | B-RAF is a therapeutic target in melanoma |
| Q24809688 | BAG-1 haplo-insufficiency impairs lung tumorigenesis |
| Q40604938 | Bovine pituitary extract provides remarkable protection against oxidative stress in human prostate epithelial cells |
| Q35992390 | Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway |
| Q36484538 | Cerebral preconditioning and ischaemic tolerance |
| Q35594372 | Chick embryo chorioallantoic membrane (CAM): an alternative predictive model in acute toxicological studies for anti-cancer drugs. |
| Q37283736 | Clinical experience and critical evaluation of the role of sorafenib in renal cell carcinoma. |
| Q35928569 | Combination therapy targeting the tumor microenvironment is effective in a model of human ocular melanoma |
| Q35634546 | Conferring specificity on the ubiquitous Raf/MEK signalling pathway |
| Q35906074 | Connecting proliferation and apoptosis in development and disease |
| Q28513466 | Cortical migration defects in mice expressing A-RAF from the B-RAF locus |
| Q34289211 | Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives |
| Q37707060 | DUSP1 inhibits cell proliferation, metastasis and invasion and angiogenesis in gallbladder cancer |
| Q36284940 | Deciphering the Key Features of Malignant Tumor Microenvironment for Anti-cancer Therapy |
| Q40819992 | Diagnostic and prognostic markers in differentiated thyroid cancer |
| Q30441862 | Differential alphav integrin-mediated Ras-ERK signaling during two pathways of angiogenesis |
| Q40601142 | Differential regulation of VEGF, HIF1alpha and angiopoietin-1, -2 and -4 by hypoxia and ionizing radiation in human glioblastoma |
| Q27000037 | Disintegrins from snake venoms and their applications in cancer research and therapy |
| Q33732613 | Disruption of angiogenesis and tumor growth with an orally active drug that stabilizes the inactive state of PDGFRbeta/B-RAF. |
| Q37574057 | Disruption of the Rb--Raf-1 interaction inhibits tumor growth and angiogenesis |
| Q33782337 | Disruption of the Shc/Grb2 complex during abelson virus transformation affects proliferation, but not apoptosis |
| Q34911374 | Disruption of the transcription factor Nrf2 promotes pro-oxidative dendritic cells that stimulate Th2-like immunoresponsiveness upon activation by ambient particulate matter |
| Q36631240 | Distinct angiogenic mediators are required for basic fibroblast growth factor- and vascular endothelial growth factor-induced angiogenesis: the role of cytoplasmic tyrosine kinase c-Abl in tumor angiogenesis |
| Q24302442 | Dynamic changes in C-Raf phosphorylation and 14-3-3 protein binding in response to growth factor stimulation: differential roles of 14-3-3 protein binding sites |
| Q34988815 | Effects of neurolytic celiac plexus block on liver regeneration in rats with partial hepatectomy |
| Q30480350 | Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation. |
| Q30495159 | Endothelial lumen signaling complexes control 3D matrix-specific tubulogenesis through interdependent Cdc42- and MT1-MMP-mediated events |
| Q33518538 | Erk1 and Erk2 regulate endothelial cell proliferation and migration during mouse embryonic angiogenesis |
| Q36685121 | Essential role for endocytosis in the growth factor-stimulated activation of ERK1/2 in endothelial cells. |
| Q37291647 | Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis. |
| Q54590204 | Ex vivo generation of a highly potent population of circulating angiogenic cells using a collagen matrix. |
| Q35649477 | Fibrosis and diseases of the eye. |
| Q34717950 | Focal adhesion kinase controls cellular levels of p27/Kip1 and p21/Cip1 through Skp2-dependent and -independent mechanisms. |
| Q41785401 | Formation of endothelial lumens requires a coordinated PKCepsilon-, Src-, Pak- and Raf-kinase-dependent signaling cascade downstream of Cdc42 activation |
| Q37999967 | From genes to drugs: targeted strategies for melanoma |
| Q24302321 | GRP78 and Raf-1 cooperatively confer resistance to endoplasmic reticulum stress-induced apoptosis |
| Q35057361 | Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium |
| Q36021580 | Genetic and hypoxic regulation of angiogenesis in gliomas |
| Q33388951 | IQGAP1-dependent signaling pathway regulates endothelial cell proliferation and angiogenesis |
| Q36820584 | Inhibition of corneal neovascularization with the combination of bevacizumab and plasmid pigment epithelium-derived factor-synthetic amphiphile INTeraction-18 (p-PEDF-SAINT-18) vector in a rat corneal experimental angiogenesis model |
| Q39031255 | Integrin inhibition promotes atypical anoikis in glioma cells |
| Q38501776 | Integrin-mediated cell-matrix interaction in physiological and pathological blood vessel formation |
| Q49547857 | Integrin-β5, a miR-185-targeted gene, promotes hepatocellular carcinoma tumorigenesis by regulating β-catenin stability |
| Q35962963 | Integrins and angiogenesis |
| Q29614536 | Integrins in cancer: biological implications and therapeutic opportunities |
| Q27001182 | Involvement of 14-3-3 Proteins in Regulating Tumor Progression of Hepatocellular Carcinoma |
| Q24613766 | MicroRNA-mediated regulation of the angiogenic switch |
| Q50423780 | Molecular Regulation of Sprouting Angiogenesis |
| Q37863911 | Molecular basis for endothelial lumen formation and tubulogenesis during vasculogenesis and angiogenic sprouting |
| Q37323503 | Molecular characterization of the cytotoxic mechanism of multiwall carbon nanotubes and nano-onions on human skin fibroblast |
| Q30923775 | Non-receptor tyrosine kinase Src is required for ischemia-stimulated neuronal cell proliferation via Raf/ERK/CREB activation in the dentate gyrus |
| Q39202040 | Norcantharidin inhibits tumor angiogenesis via blocking VEGFR2/MEK/ERK signaling pathways |
| Q37681157 | Novel aspects of corneal angiogenic and lymphangiogenic privilege. |
| Q40560449 | Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs. |
| Q30427989 | Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer |
| Q99630289 | P21-Activated Kinase 1: Emerging biological functions and potential therapeutic targets in Cancer |
| Q41857137 | PAI-1 is a Critical Upstream Regulator of the TGF-beta1/EGF-Induced Invasive Phenotype in Mutant p53 Human Cutaneous Squamous Cell Carcinoma |
| Q47736652 | PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas |
| Q28307460 | PAK signalling during the development and progression of cancer |
| Q35108164 | PAK1 as a therapeutic target |
| Q36742274 | Pathophysiology of tumor neovascularization |
| Q38166233 | Personalizing colon cancer therapeutics: targeting old and new mechanisms of action. |
| Q57916044 | Physiological Role of Vascular Endothelial Growth Factors as Homeostatic Regulators |
| Q37023814 | Plasmalemmal vacuolar H+-ATPases in angiogenesis, diabetes and cancer |
| Q40174425 | Protection against myocardial ischemia-reperfusion injury by the angiogenic Masterswitch protein PR 39 gene therapy: the roles of HIF1alpha stabilization and FGFR1 signaling |
| Q92092913 | RAF dimers control vascular permeability and cytoskeletal rearrangements at endothelial cell-cell junctions |
| Q24337730 | RKTG inhibits angiogenesis by suppressing MAPK-mediated autocrine VEGF signaling and is downregulated in clear-cell renal cell carcinoma |
| Q39912763 | RNAi-mediated inhibition of Raf-1 leads to decreased angiogenesis and tumor growth in gastric cancer |
| Q34320910 | Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules |
| Q35647943 | Radiation attenuates physiological angiogenesis by differential expression of VEGF, Ang-1, tie-2 and Ang-2 in rat brain |
| Q28237793 | Raf kinases in cancer-roles and therapeutic opportunities |
| Q36002845 | Raf kinases: function, regulation and role in human cancer |
| Q40450443 | Redox control of angiogenic factors and CD31-positive vessel-like structures in mouse embryonic stem cells after direct current electrical field stimulation. |
| Q24320264 | Regulation of RAF activity by 14-3-3 proteins: RAF kinases associate functionally with both homo- and heterodimeric forms of 14-3-3 proteins |
| Q37302754 | Regulation of angiogenesis: apoptotic cues from the ECM. |
| Q28577191 | Regulation of the Raf-MEK-ERK pathway by protein phosphatase 5 |
| Q38230951 | Rho GTPases modulate malignant transformation of tumor cells |
| Q24798542 | Signaling through Raf-1 in the neovasculature and target validation by nanoparticles |
| Q36911934 | Sorafenib in Platinum-Treated Patients with Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group (SWOG 0435) Phase II Trial |
| Q36880854 | Structural and Functional Analysis of a Talin Triple-Domain Module Suggests an Alternative Talin Autoinhibitory Configuration |
| Q38779105 | Structure, biochemistry, and biology of PAK kinases |
| Q38907899 | T11TS inhibits Angiopoietin-1/Tie-2 signaling, EGFR activation and Raf/MEK/ERK pathway in brain endothelial cells restraining angiogenesis in glioma model |
| Q40320864 | TGF-beta 1-induced PAI-1 expression is E box/USF-dependent and requires EGFR signaling |
| Q53821423 | TGF-β, Fibronectin and Integrin α5β1 Promote Invasion in Basal Cell Carcinoma. |
| Q36293115 | Targeted agents for the treatment of advanced renal cell carcinoma |
| Q35030974 | Template-based de novo design for type II kinase inhibitors and its extented application to acetylcholinesterase inhibitors. |
| Q29620153 | The RAF proteins take centre stage |
| Q35544693 | The early responses of VEGF and its receptors during acute lung injury: implication of VEGF in alveolar epithelial cell survival. |
| Q51328396 | The lack of Raf-1 kinase feedback regulation enhances antiapoptosis in cancer cells. |
| Q52309706 | VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease. |
| Q34333828 | VEGFR-1 and VEGFR-2: two non-identical twins with a unique physiognomy |
| Q35049227 | Vascular endothelial growth factor receptors: molecular mechanisms of activation and therapeutic potentials. |
| Q55456982 | When and why is surgical revascularization indicated for the treatment of moyamoya syndrome in patients with RASopathies? A systematic review of the literature and a single institute experience. |
| Q37145380 | Whole brain radiation-induced cognitive impairment: pathophysiological mechanisms and therapeutic targets |
| Q28301018 | X-linked and cellular IAPs modulate the stability of C-RAF kinase and cell motility |
| Q48390858 | c-jun amino-terminal kinase and mitogen activated protein kinase 1/2 mediate hepatocyte growth factor-induced migration of brain endothelial cells |
| Q21134956 | p21-Activated kinase 1 (Pak1) phosphorylates BAD directly at serine 111 in vitro and indirectly through Raf-1 at serine 112 |
| Q56567258 | von Hippel–Lindau-associated malignancies: Mechanisms and therapeutic opportunities |
| Q26851768 | αV integrins in angiogenesis and cancer |
Search more.